Cargando…
Evaluating the prognostic value of CD56 in pediatric acute myeloid leukemia
BACKGROUND: Many cytogenetic changes and gene mutations are associated with acute myeloid leukemia (AML) survival outcomes. CD56 is related to poor prognosis when expressed in adult AML patients. However, the prognostic value of CD56 in children with AML has rarely been reported. In this research, w...
Autores principales: | Liang, Tianqi, Peng, Zhiyong, Li, Chunfu, Huang, Junbin, Wang, Huabin, Bu, Chaoke, Li, Jian, Zheng, Yongzhi, Feng, Xiaoqin, Li, Huiping, Chen, Chun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768963/ https://www.ncbi.nlm.nih.gov/pubmed/36544113 http://dx.doi.org/10.1186/s12885-022-10460-3 |
Ejemplares similares
-
Prognostic Significance of CD56 Antigen Expression in Patients with De Novo Non-M3 Acute Myeloid Leukemia
por: Sun, Yanni, et al.
Publicado: (2021) -
Clinical Significance of CD200 and CD56 Expression in Patients with Acute Myeloid Leukemia
por: Aref, Salah, et al.
Publicado: (2020) -
The expression of CD56 antigen is associated with poor prognosis in patients with acute myeloid leukemia
por: Alegretti, Ana Paula, et al.
Publicado: (2011) -
The expression of the CD56 antigen is associated with poor prognosis in patients with acute myeloid leukemia
por: Rego, Eduardo Magalhães
Publicado: (2011) -
High EVI1 Expression Predicts Adverse Outcomes in Children With De Novo Acute Myeloid Leukemia
por: Zheng, Yongzhi, et al.
Publicado: (2021)